<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-974
Date of Submission: 2024-11-15

This report was submitted by a Physician from Orr, Bell and Wolf Medical Center concerning patient ANON-PX-4008. The subject is a 34-year-old other with a significant medical history including osteoarthritis, migraines, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Atorvastatin (Statin) administered via the Intramuscular route at a dosage of 385mg, initiated on 2024-09-20 for Hypercholesterolemia and discontinued on 2024-10-21.

On approximately 2024-09-26, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Pruritus, Dizziness. The Pruritus was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed marriage and advised commercial. The current patient status regarding this symptom is 'Not Recovered'. The Dizziness was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed free and advised party. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 8 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2024-974
report_date: '2024-11-15'
patient_details:
  patient_id: ANON-PX-4008
  gender: Other
  relevant_history:
  - osteoarthritis
  - migraines
  - chronic kidney disease
  age_at_reaction: 34
suspected_drugs:
- drug_name: Atorvastatin
  dosage: 385mg
  route_of_administration: Intramuscular
  start_date: '2024-09-20'
  indication_for_use: Hypercholesterolemia
  drug_class: Statin
  end_date: '2024-10-21'
adverse_reactions:
- symptom_name: Pruritus
  onset_date: '2024-09-26'
  severity: Mild
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed marriage and advised commercial.
- symptom_name: Dizziness
  onset_date: '2024-09-26'
  severity: Severe
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed free and advised party.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
  naranjo_score: 8
reporting_facility: Orr, Bell and Wolf Medical Center
reporter_type: Physician
